| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 257,888,364.72 | 132,891,352.36 | 306,969,792.52 | 229,221,857.21 |
| 收到的税费返还 | 19,454,766.64 | 12,570,974.66 | 23,356,324.01 | 21,750,402.75 |
| 收到其他与经营活动有关的现金 | 2,647,792.32 | 1,040,521.14 | 3,783,520.12 | 4,214,028.17 |
| 经营活动现金流入小计 | 279,990,923.68 | 146,502,848.16 | 334,109,636.65 | 255,186,288.13 |
| 购买商品、接受劳务支付的现金 | 93,267,454.04 | 49,889,096.17 | 221,727,585.32 | 150,831,690.01 |
| 支付给职工以及为职工支付的现金 | 38,313,224.3 | 20,582,513.8 | 75,361,712.24 | 55,154,700.78 |
| 支付的各项税费 | 6,188,640.1 | 3,134,029.45 | 8,689,449.83 | 7,200,097.97 |
| 支付其他与经营活动有关的现金 | 13,153,970.41 | 8,805,324.18 | 15,298,638.36 | 22,569,420.59 |
| 经营活动现金流出小计 | 150,923,288.85 | 82,410,963.6 | 321,077,385.75 | 235,755,909.35 |
| 经营活动产生的现金流量净额 | 129,067,634.83 | 64,091,884.56 | 13,032,250.9 | 19,430,378.78 |
| 二、投资活动产生的现金流量: | | | | |
| 收回投资收到的现金 | 263,972,755.61 | 45,222,591.94 | 228,647,782.11 | 138,499,467.15 |
| 取得投资收益收到的现金 | 435,005.03 | 158,441.97 | 537,899.12 | 613,581.33 |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | - | - | 62,792 | 61,026 |
| 收到的其他与投资活动有关的现金 | - | 6,610,143.9 | - | - |
| 投资活动现金流入小计 | 264,407,760.64 | 51,991,177.81 | 229,248,473.23 | 139,174,074.48 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 31,766,477.61 | 13,727,041.82 | 47,281,972.92 | 37,312,437.95 |
| 投资支付的现金 | 378,033,765.97 | 43,141,538.25 | 207,078,995.45 | 114,435,660.45 |
| 支付其他与投资活动有关的现金 | - | - | 14,089,173.8 | - |
| 投资活动现金流出小计 | 409,800,243.58 | 56,868,580.07 | 268,450,142.17 | 151,748,098.4 |
| 投资活动产生的现金流量净额 | -145,392,482.94 | -4,877,402.26 | -39,201,668.94 | -12,574,023.92 |
| 三、筹资活动产生的现金流量: | | | | |
| 吸收投资收到的现金 | - | - | 490,000 | 490,000 |
| 其中:子公司吸收少数股东投资收到的现金 | - | - | 490,000 | 490,000 |
| 取得借款收到的现金 | 54,900,000 | 45,000,000 | 29,800,000 | 19,900,000 |
| 收到其他与筹资活动有关的现金 | 14,089,173.8 | - | - | 6,483,097.5 |
| 筹资活动现金流入小计 | 68,989,173.8 | 45,000,000 | 30,290,000 | 26,873,097.5 |
| 偿还债务支付的现金 | 20,800,000 | 10,900,000 | 9,050,000 | 50,000 |
| 分配股利、利润或偿付利息支付的现金 | 18,108,161.21 | 403,736.45 | 17,758,676.24 | 17,622,426.39 |
| 支付其他与筹资活动有关的现金 | 227,500 | - | 900,000 | 15,345,879.4 |
| 筹资活动现金流出小计 | 39,135,661.21 | 11,303,736.45 | 27,708,676.24 | 33,018,305.79 |
| 筹资活动产生的现金流量净额 | 29,853,512.59 | 33,696,263.55 | 2,581,323.76 | -6,145,208.29 |
| 四、汇率变动对现金及现金等价物的影响 | -562,928.18 | 341,071.57 | 57,709.56 | 826,362.46 |
| 五、现金及现金等价物净增加额 | 12,965,736.3 | 93,251,817.42 | -23,530,384.72 | 1,537,509.03 |
| 加:期初现金及现金等价物余额 | 128,882,122.09 | 128,882,122.09 | 152,412,506.81 | 152,412,506.81 |
| 期末现金及现金等价物余额 | 141,847,858.39 | 222,133,939.51 | 128,882,122.09 | 153,950,015.84 |
| 补充资料: | | | | |
| 净利润 | 9,817,579.99 | - | 27,490,186.03 | - |
| 资产减值准备 | -172,343.83 | - | 348,365.89 | - |
| 固定资产和投资性房地产折旧 | 3,314,452.32 | - | 7,072,746.65 | - |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 3,314,452.32 | - | 7,072,746.65 | - |
| 无形资产摊销 | 521,065.93 | - | 468,036.29 | - |
| 长期待摊费用摊销 | 145,731.5 | - | 405,867.04 | - |
| 处置固定资产、无形资产和其他长期资产的损失 | - | - | -8,418.08 | - |
| 公允价值变动损失 | -603,334.93 | - | -110,451.54 | - |
| 财务费用 | 1,106,815.78 | - | 331,606.62 | - |
| 投资损失 | 99,393.91 | - | -1,604,777.73 | - |
| 递延所得税 | 168,553.4 | - | -568,755.07 | - |
| 其中:递延所得税资产减少 | 168,553.4 | - | -568,755.07 | - |
| 存货的减少 | -1,375,423.72 | - | 3,521,580.75 | - |
| 经营性应收项目的减少 | 68,309,062.65 | - | -31,582,405.85 | - |
| 经营性应付项目的增加 | 49,590,248.19 | - | 3,782,658.48 | - |
| 现金的期末余额 | 141,847,858.39 | - | 128,882,122.09 | - |
| 减:现金的期初余额 | 128,882,122.09 | - | 152,412,506.81 | - |
| 现金及现金等价物的净增加额 | 12,965,736.3 | - | -23,530,384.72 | - |
| 公告日期 | 2025-08-26 | 2025-04-25 | 2025-04-25 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |